Edition:
India

Immune Pharmaceuticals Inc (IMNP.OQ)

IMNP.OQ on NASDAQ Stock Exchange Capital Market

0.37USD
22 Feb 2018
Change (% chg)

-- (--)
Prev Close
$0.37
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
218,912
52-wk High
$5.02
52-wk Low
$0.33

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.534
Jun '17 0.00 -0.500
Mar '17 0.00 -0.427
FY 2016 Dec '16 0.00 -1.538
Sep '16 0.00 -3.139
Jun '16 0.00 -2.659
Mar '16 0.00 -3.486
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Earnings (per share)
Quarter Ending Mar-18 1 -0.11 -0.11 -0.11 --
Quarter Ending Jun-18 1 -0.12 -0.12 -0.12 --
Year Ending Dec-18 1 -0.43 -0.43 -0.43 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.10 32.90
P/E High - Last 5 Yrs. -- 40.92 45.97
P/E Low - Last 5 Yrs. -- 23.79 24.37
Beta 2.17 0.90 0.89
Price to Sales (TTM) -- 3.98 5.77
Price to Book (MRQ) -- 4.84 5.41
Price to Tangible Book (MRQ) -- 5.66 6.98
Price to Cash Flow (TTM) -- 23.02 23.42
% Owned Institutions 5.00 1.25 2.22

Dividends

  Company industry sector
Dividend Yield -- 1.57 1.50
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.33 5.21
Payout Ratio(TTM) -- 45.86 43.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 3.67 9.24
Sales (TTM) vs TTM 1 Yr. Ago -- 4.72 5.59
Sales - 5 Yr. Growth Rate -- 10.02 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 81.21 16.64 19.65
EPS (TTM) vs TTM 1 Yr. Ago 69.50 -- --
EPS - 5 Yr. Growth Rate -- 9.82 10.73
Capital Spending - 5 Yr. Growth Rate -4.18 15.22 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) 0.02 2.89 2.97
LT Debt to Equity (MRQ) -- 9.91 12.22
Total Debt to Equity (MRQ) -- 13.93 16.52
Interest Coverage (TTM) -7.64 36.27 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.11 54.70
Gross Margin - 5 Yr. Avg. -- 52.40 52.42
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -301,733.31 18.51 10.86
Operating Margin (TTM) -- 14.36 4.64
Operating Margin - 5 Yr. Avg. -343,366.69 14.42 6.26
Pre-Tax Margin (TTM) -- 14.77 5.44
Pre-Tax Margin - 5 Yr. Avg. -459,700.00 14.73 6.60
Net Profit Margin (TTM) -- 11.05 1.76
Net Profit Margin - 5 Yr. Avg. -436,680.91 11.07 2.91
Effective Tax Rate (TTM) -- 23.16 23.04
Effective Tax Rate - 5 Yr. Avg. -- 23.41 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 948,737,942 855,668,157
Net Income/Employee (TTM) -3,618,000 111,622,123 100,655,595
Receivable Turnover (TTM) -- 5.62 5.78
Inventory Turnover (TTM) -- 2.58 3.35
Asset Turnover (TTM) 0.00 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -120.00 11.45 10.98
Return on Assets - 5 Yr. Avg. -74.56 12.98 12.37
Return on Investment (TTM) -201.88 14.90 14.43
Return on Investment - 5 Yr. Avg. -109.15 16.98 16.18
Return on Equity (TTM) -1,487.29 16.41 16.13
Return on Equity - 5 Yr. Avg. -477.80 18.08 17.47
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 46.87 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Immune Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 3.84%
# of Holders: 17
Total Shares Held: 688,329
3 Mo. Net Change: 335,860
# New Positions: 5
# Closed Positions: 3
# Increased Positions: 8
# Reduced Positions: 3
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.